info@clinicaloncologyjournal.com

Azza Mahmoud Kamel

Azza Mahmoud Kamel

Azza Mahmoud Kamel

M.B., B.Ch., MD Cairo University , Department of Pathology Egypt

BIOGRAPHY 22 PUBLICATIONS 100 ACCOMPLISHMENTS 7

We cordially invite you to join our board.

Your valuable suggestions improve our journal quality. We welcome you to be part of our board members.

Join Board

Academic Qualifications

  • June 1968: Medical Degree (M.B., B.Ch.), Faculty of Medicine - Cairo University, Cairo, Egypt.
  • October 1972: Master Degree (M. Sc.) in Clinical Pathology, Faculty of Medicine - Cairo University, Cairo, Egypt.
  • July 1976: Doctorate Degree (MD) in Clinical Pathology (Immunology/Haematology), Faculty of Medicine - Cairo University, Cairo, Egypt.

Professional Experience

  • House officer at Cairo University hospitals for one year (1968 - 1969). 
  • Resident of General Medicine, Faculty of Medicine, Cairo University, for six months (1969 - 1970). 
  • Resident of Clinical Pathology, National Cancer Institute, Cairo University, for two years (1970 - 1972). 
  • Assistant Lecturer of Clinical Pathology, National Cancer Institute, Cairo University, for four years (1972 - 1976). 
  • Lecturer of Clinical Pathology, National Cancer Institute, Cairo University, for five years (1976 - 1981). 
  • Assistant Professor of Haematology at King Abdul-Aziz University, Jeddah, Kingdom of Saudi Arabia, for four years (1977 - 1981). 
  • Assistant Professor of Clinical Pathology, National Cancer Institute, Cairo University, for five years (1981 - 1986). 
  • Six month-visit to various immunology department at L'Institue Gustave-Roussy, Villejuif, France (1984 - 1985), main training with Thomas Turz (Laboratoire d'Immunologie des Tumeurs, UA 207 au CNRS). 
  • Visit to the National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA (1985). 
  • Five-week visit to the Immunogenetics Department, University of Essen, Germany (1988). 
  • Four-month training at Fred Hutchinson Cancer Research Center, Seattle, Washington, USA (1990), main training in the "molecular typing of HLA" and Flow cytometry.
  • Two weeks visit to St Jude's Children Hospital, Memphis, USA, March, 2004 as a PI of a conjoint research project.
  • Two weeks visit to Fred Hutchinson Cancer Research Center, Seattle, USA, July, 2004 as the PI of a conjoint research project.
  • Two weeks visit to St Jude's Children Hospital, Memphis, USA, March, 2005 as a PI of a conjoint research project. During the visit got oriented with the stem cell lab activities for haploidentical transplantation as well as with KIR receptor/legend evaluation for the choice of a donor with perfect KIR mismatch.
  • Two weeks visit to Flow Cytometry Lab. Roswell Park Hospital, Buffalo, July, 2005, as a PI of a conjoint research project. During the visit attended a one week workshop on Flow cytometry.
  • One weeks visit to Fred Hutchinson Cancer Research Center, Seattle, USA, March, 2008 as the PI of a conjoint research project.
  • One week visit to Cytometry Lab. Roswell Park Hospital, Buffalo, March, 2008, as a PI of a conjoint research project. 
  • Two weeks visit to St Jude's Children Hospital, Memphis, USA, March, 2012 as a PI of a conjoint research project.
  • Two weeks visit to St Jude's Children Hospital, Memphis, USA, May, 2012 as a PI of a conjoint research project.

Recent 100 Publications

  • Decreased incidence of acute and chronic graft versus host disease following primary transplantation of allogeneic peripheral blood stem cells in patients with severe aplastic anemia, The 42nd annual meeting of the American Society of Hematology, San Francisco, California, USA, December, 2000.
  • Zekri AR, El-Mahallawy HA, Hassan A, El-Din NH, Kamel AM. Influence of HLA alleles on susceptibility to HCV infection and its impact on intrafamilial transmission, Egypt J of Med. Microbiology, 9 : (4) : 753 759, 2000. PMID: 16734142 [PubMed - indexed for MEDLINE].
  • Kamel A, Mokhtar N, Elshakankiry N, Yassin D, Elnahass Y, Zakarya O, Elbasmy A, Elmettenawy A: Cell cycle proteins (p53, cyclin D1 and p27) in breast cancer. The 5th International Conference of Oncology: Breast Cancer. Sharm El-Sheikh, Egypt, March, 2001.
  • Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhães IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Research, 61 : 2542-2546, 2001. PMID: 11289128 [PubMed - indexed for MEDLINE]
  • Kamel AM, El-Sharkawy N, Zekri ZK, Khaled H, El-Akkad MA, and Hassan MT. The expression of p53 proteins in chronic lymphocytic leukemia is associated with poor response to chemotherapy and short survival, J. Egypt. Natl Cancer Inst, 13 (1) : 19-26, 2001.
  • Kamel AM, El-Sharkawy NM, Ghaleb FM, Shaker HM, Yasin DA, and Hamdy N. A suggested algorithm for the diagnosis of biphenotypic leukemia: a new approach to an old problem. 6th Meeting of the European Association of Hematology, Frankfurt, Germany, June, 2001.
  • Kamel AM. A cost benefit approach for the diagnosis and management of anemia in a developing country. 3rd Meeting of the European Society of Pediatric Hematology and Immunology, Lucerne, Switzerland, June, 2001  .
  • El-Mehallawy H, Salah F, El-Sharkawy N, El-Haddad A, El-Attar I, Fahmy O, Mahmoud H,  and Kamel A Level and onset of CMV-pp65 antigenemia as determinants of risk for  CMV- related complications in stem cell transplant recipients, J Egypt Natl Cancer Inst, 13: 259-266, 2001.
  • Mahmoud H, Fahmy O, Kamel A, Kamel M, El-Haddad A. Nonmyeloablative transplants for hematological disorders. The 7th Annual Congress of the Egyptian Association of Immunologists: Immunomodulation. Ein Sukhna, Egypt, January, 2001.
  • Hendy OM, Abdel-Moemen K, El-Sharkawy NM, El-Hadad O, and Kamel AM. Lack of peripheral blood CD5+ B lymphocytes expansion in Egyptian chronic hepatitis C patients. Egypt J Haematol, 27: 125-137, 2002..
  • Kamel, AM. Detection of chimerism in allogeneic BMT: Methodology and clinical significance. The XVI Meeting of the International Society of Hematology, European and African Division, Cairo, Egypt, January, 2002.
  • Mahmoud H, Fahmy O, Kamel A, Kamel M, El-Haddad A, El-Kadi D. Peripheral blood: The challenge in hemopoietic stem cell transplantation. The XVI Meeting of the International Society of Hematology, European and African Division, Cairo, Egypt, January, 2002.
  • Kamel AM, El-Missiry A, El-Khodary A, Abd El-Alim S, Teama S, and Sharef M. Evaluation of iNOS expression in PBMC of HCC patients by gel documentation and real time PCR. ESLM'S First Arab Conference, Advanced Laboratory Technology: The Quest for the Best. Cairo, Egypt, April, 2002.
  • Kamel AM, El-Missiry A, El-Khodary A, Abd El-Alim S, Teama S, and Sharef M. Kamel AM, El-Missiry A, El-Khodary A, Abd El-Alim S, Teama S, and Sharef M. PBMC iNOS as a potential tumor marker in hepatocellular carcinoma. The 6th International Conference of Oncology: Towards Healthy Liver. Ein Sukhna, Egypt, April, 2002.
  • Kamel A, El Sharkawy N, Mahmoud HK, Khalaf MR, El Haddad A, Fahmy O, Abd El Fattah R and Sayed D: Impact of graft components on engraftment kinetics in PBSC transplantation. The 29th World Congress of the International Society of Hematology, Seoul, Korea, August, 2002.
  • Kamel AM, El-Missiry A, El-Khodary A, Abd El-Alim S, Teama S, and Sharef M. Peripheral blood mononuclear cell (PBMC) inducible nitric oxide synthase (iNOS) expression and activity as a potential tumor marker in hepatocellular carcinoma (HCC). J Egypt Natl Cancer Inst, 14: 145-151, 2002.
  • Kamel AM, El-Sharkawy NM, Khalaf MR, Galal SH, Ghaleb FM, and El-Ghazaly T. CD117 expression and serum CD117 in acute non lymphoid leukemia. J Egypt Natl Ca Inst, 14: 243-49, 2002. 
  • Kamel AM, Mossallam GI, Mahmoud HK, Hamdy N, El-Haddad A, Fahmy O, and Nassar AA. Variable number tandem repeat polymorphism as a tool of chimerism detection in allogeneic stem cell transplantation. J Egypt Natl Ca Inst, 14: 275-87, 2002.
  • Safwat A, Bayoumy Y, El-Sharkawy N, Shaaban K, Mansour O, Kamel A. The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma. Radiotherapy and Oncology, 69: 33-36, 2003. PMID: 14597354 [PubMed - indexed for MEDLINE]
  • El-Sharkawy NM, Hamdy N, Attia E, Ghaleb FM, Abdel-Ghani NA, Shaaban K, Abdel-Kader I, and Kamel AM. Soluble CD44 as a potential marker of tumor load in pediatric acute leukemia. J Egypt Natl Ca Inst, 15:129-135, 2003.
  • Kamel AM, El Sharkawy NM, Shaaban K, Yassin DA, Sidhom I, Abo EL Naga S, El Hattab O: MDR 1 expression and functional assay have no impact on survival in Egyptian pediatric acute leukemia patients. The 8th Congress of the European Hematology Association, Lyon, France, 12-15 June, 2003.
  • Yassin D, Kamel A, Taha H, Lotayef M, Hassan Y, Fawzy A and Akl S: HER family expression in Egyptian breast cancer patients. J Egypt Natl Cancer Inst, 15: 373-380, 2003. 
  • Fahmy O.A.; Mahmoud H.K.; Haddad A.; El Badrawy S.; Kamel A.; Sedky H.; Abdel Latif S.; Abdel Moaty M.; Abdel Fattah R.; Sobhy A.; Nasar M.; El Emary M.; Rabie T.; Adel N.; Helmy E.  Hematopoietic stem cell transplantation: The Nasser Institute experience. Egyptian Journal of Haematology. September 2003, Vol. (28) No (4) (supp.): 1001-1018.
  • Hussein H, Sidhom I, Naga SA, Amin M, Ebied E, Khairy A, Kamel A, El-Sharkawy N. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol. 2004 Aug; 26(8):507-14. PMID: 15284589 [PubMed - indexed for MEDLINE]
  • El-Houseini ME, Abdel-Azim SA, El-Desouky GI, Abdel-Hady S, El-Hamad MF, Kamel AM. Clinical significance of vascular endothelial growth factor (VEGF) in sera of patients with pediatric malignancies. J Egypt Natl Canc Inst. 2004 Mar; 16(1):57-61.  PMID: 15716999 [PubMed]
  • Kamel A, El Sharkawy N, Mahmoud HK, Khalaf MR, El Haddad A, Fahmy O, Abd El Fattah R and Sayed D: Impact of CD34 Subsets on Engraftment Kinetics in Allogeneic Peripheral Blood Stem Cell Transplantation. Bone Marrow Transplantation 35: 129-136, 2005.  PMID: 15568034 [PubMed - indexed for MEDLINE].
  • Ahmed Morsi; Hossam A. Kamel; Gamal Emira; Omar Z. Youssef; Ahmed I. El-Khodary; Azza M. Kamel; Rabab M. Gaafar; Mohamed Abdel Mooti. High-dose Chemotherapy Versus Conventional-Dose Chemotherapy as an Adjuvant Treatment after Mastectomy for Locally Advanced Breast Cancer: A Prospective Randomized Trial. The Medical Journal of Cairo University, June 2004, Vol. (72), No. (2), Suppl. (II): 147-153. IF= 0.24
  • Zekri AR, El-Mahallawy HA, Hassan A, El-Din NH, Kamel AM. HLA alleles in Egyptian HCV genotype-4 carriers. Egypt J Immunol. 2005; 12(1):77-86.  PMID: 16734142 [PubMed - indexed for MEDLINE]
  • Assem MM, Gad WH, El-Sharkawy NM, El-Rouby MN, Ghaleb FM, Tarek H, Kamel AM. Prevalence of anti human herpes virus-6 IgG and its receptor in acute leukemia (membrane cofactor protein: MCP, CD46). J Egypt Natl Canc Inst. 2005 Mar; 17(1):29-34. PMID: 16353080 [PubMed - indexed for MEDLINE.
  • Kamel A, El Sharkawy N, Moussa H, Yassin D, Abdel Hamid T, Shaaban K, , Mossalam G, Elnahass Y: MPO Antigen Negative HLA-DR Negative Acute Myeloid Leukemia: Is It a Separate Clinical Entity.  The Journal of  Eg Soc Haematol and Res 1:7-14, 2005 
  • Kamel A, El Sharkawy N, Yassin D, Sidhom I,  Shaaban K, Moussa H, Mossalam G, Elnahass Y , Zamzam M , Ebaid E, Abo El Naga S, Hussein H: Prognostic Significance of Natural Killer Expression in Egyptian Pediatric Acute Myeloid Leukemia. Egypt J Haematol 30: 455-468, 2005
  • Kamel A, El Sharkawy N, Yassin D, Shaaban K, Hussein H, Sidhom E, Abo EL Naga S, Ameen M, El Hattab O and Aly El-Din N: P-gp expression and RH 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients. J. Egypt. NCI. 17:158-165, 2005. PMID: 16799654 [PubMed - indexed for MEDLINE]
  • Ragab MS, Essmat SM, Bassiouny DA, Abdel-Halim MRE, El-Hadidi HH, El-Sharkawy N, Ghaleb FM, Maghrabi SM, and Kamel AM: Effect of staphylococcal colonization and exotoxin production on apoptosis in atopic dermatitis. J Egypt Dermatol Soc. 2: 17-24, 2005
  • Abdel Hamid TM, Mahmoud HK, Kamel AM, Shaker H, El Sharkawy N, and Ali El-Din NH. Risk adapted chemotherapy treatment for adult acute lymphoblastic leukemia. The Egypt J of Hematol, 2005, 30: 579-593
  • Kamel AM, El-Sharkawy M, Yassin D, Shaaban K, Hussein H, Sedhom I, Abo El-Naga S, Ameen M, El-hattab O, Aly El-Din N. P-gp expression and Rh 123 efflux assay have no impact on survival in Egyptian pediatric acute lymphoblastic leukemia patients. JENCI 17:158-165, 2005
  • Kamel A, Thabet G, BU R, Moussa H, Bhatia K: Synergistic effect of methyltetrahydropholate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric ALL. INCTR Annual Meeting, India, 10-13 December 2005. 
  • Kamel AM, El-Nahass YH, Yassin D, Moussa H, Girtman K, Mohar K, El-Sharkawy N, Shaaban K, Shurtleff S: Molecular characterization of pediatric precursor B ALL in Egypt. INCTR Annual Meeting, India, 10-13 December 2005. 
  • Kamel A, Mokhtar N, Elshakankiry N, Yassin D, Elnahass Y, Zakarya O, Elbasmy A, Elmettenawy A: The Prognostic impact of some cell cycle regulatory proteins in Egyptian breast cancer patients. J. Egypt. NCI. 18: 93-102, 2006. PMID: 17496933 [PubMed - indexed for MEDLINE]
  • Bakry RM, Mossallam G, Khalaf MR, Kamel AM, Albert E: Molecular   analysis of HLADRB1, DQB1 and DRB4 in acute lymphoblastic leukemia. Egypt. J Lab. Med., 18: 83-95, 2006 
  • Abdel Hamid, Th; Ali, NM; Kamel, AM; El-Sharkawy, NH; Zaher, A; Francis, NF. Fludarabine and cyclophosphamide (FC) versus cyclophosphamide, vincristine and prednisone (CVP) as first line treatment in chronic lymphocytic leukaemia (CLL). 11th Congress of the European Hematology Association, Amesterdam, June, 2006
  • Kamel AM, El-Nahass YH, Sidhom I, Moussa HS, Yassin DA, El-Sharkawy N, Shaaban K, Hussein H, Aboul-Naga S, Zekry W, Ebeid E, Zamzam M, El-Haddad A: Molecular characterization of pediatric acute lymphoblastic leukemia in Egypt.  Egypt. J Haematol. 31: 425-40, 2006 
  • Kamel AM. Pattern of Pediatric ALL in Egypt. The first Moroccan/Egyptian Oncology Conference (Hands in Hands against Cancer), Marrakech, Morocco, 1-3 March, 2007.
  • Kamel AM, Moussa HS, El-Nahass YH, El-Sharkawy NM, Yassin DA, Shaaban KM and Sidhom I. Morphological and Immunophenotypic Heterogeneity of Pediatric Acute Megakaryoblastic Leukemia (M7). J Egypt. Soc. Hematol & Research. 3 (1): 23-35, March, 2007 
  • Kamel AM, El-Nahass YH, Sidhom IA, Girtman KL, Moussa HS, Yassin DA, El-Sharkawy NM, Shaaban KM, Hussein HM, Aboul-Naga SM, Zekry WM, Ebeid EN, Zamzam MA,  El-Haddad AM and Shurtleff SA. E2A/PBX, t(1;19) is the predominant translocation in precursor- B pediatric ALL in Egypt with no special association with pre B phenotype. 12th Congress of the European Hematology Association, 7-10 June, Vienna, 2007.
  • El-Mehallawy H, Salah F, El-Sharkawy N, Abd El-Fattah R, El-Haddad A, El-Attar I, Fahmy O, Mahmoud H, and Kamel A. Level and onset of CMV-pp65 antigenemia as determinants of risk for  CMV- related complications in stem cell transplant recipients, International Congress on bone marrow and stem cell transplantation     KFHRC SA, November 13-15, 2007
  • Kamel AM, Mossallam GI, Adel D, Gamil H,   Ismail N, Moneer M. HLA-DQA and DQB alleles and predisposition to insulin dependent diabetes mellitus. The Egyptian Journal of Medical Human Genetics, 8 (1): 69-86 May, 2007.
  • Kamel A, Moussa HS, Ebeid GT, BU RR, Bhatia KG. Synergistic effect of methyltetrahydropholate reductase (MTHFR) C677T and A1298C polymorphism as risk modifiers of pediatric ALL. J Egypt Natl Canc Inst. 2007 Jun; 19(2):96-105.
  • Hamouda F, El-Sissy AH, Radwan Ak, Hussein H, Gadallah FH, Al-Sharkawy N, Sedhom E, Ebeid E, Salem  SI And Kamel  AM. Correlation of Karyotype and Immunophenotype in ChildhoodAcute Lymphoblastic Leukemia; Experience at the National Cancer Institute, Cairo University, Egypt. J Egypt Natl Canc Inst. 2007 Jun; 19(2):87-95.
  • Kamel AM, Thabet G, and Moussa H. N-acetyl transferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. AACR International Conference, Dead Sea, Jordan, March 16-19, 2008.  
  • Kamel A, Thabet G, BU R, Moussa H. NADPH quinone oxireductase (NQO1) as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. XXXIInd conference of the International Society of Heamatology, Bangkok, Thailand, 19-23 October, 2008
  • El-Mehallawy H, Salah F, El-Sharkawy N, Abd El-Fattah R, El-Haddad A, El-Attar I, Fahmy O, Mahmoud H, and Kamel A. Level and onset of CMV-pp65 antigenemia as determinants of risk for  CMV- related complications in stem cell transplant recipients, International Congress on bone marrow and stem cell transplantation. Saudi, Arabia, 2008
  • Mossallam GI, Kamel AM, Storer B, Martin PJ. Prognostic Utility of Routine Chimerism Testing at 2 – 6 Months after ‎Allogeneic Hematopoietic Cell Transplantation ` Biology of Blood   and Marrow Transplantation. 2009; (15)3:352-359.
  • Kamel AM. Diagnostic algorithm in acute leukemia Pan Arab Journal of Oncology: Proceedings of the 9th Pan Arab Cancer Congress , Cairo, Egypt 2009 2: 41-45
  • Kamel AM, Moussa HS, El-Nahass YH, El-Sharkawy NM, Shaaban KM, Sidhom I. and El-Haddad A. Pediatric acute megakaryoblastic leukemia (M7) shows marked morphological and immunophenotypic heterogeneity 14th Congress of the European Hematology Association, Berlin, Germany, June 4-7, 2009.
  • Radwan WM, El-Sharkawy NM, Eissa ES, Kandil SH, Kamel AM. Increased expression of brother of the regulator of imprinted sites (BORIS) expression in peripheral blood neutrophils is associated with both benign and malignant breast lesions, Second Dead Sea AACR conference, Dead Sea, Jordan, 7-10 March, 2010. 
  • Kamel A, El-Sharkawy N, Kamal E, Abd El-Fattah R,Abd El-Moeti M and Mahmoud H. Cytokine production by graft cells in response to patient's antigens may predict the occurrence of acute graft versus host disease in  allogeneic hematopoietic stem cell transplantation from a sibling. 15th Congress of the European Hematology Association (EHA): June 10-13, 2010 - Barcelona , Spain Abs code: 1077
  • Abdel Hamid T, Mahmoud H, Ezzat H, El Sharkawy N, Shaker  H, Kamel A. Prognostic factors of adult acute lymphoblastic leukemia and their impact on treatment outcome and long term survivals. Pan Arab Journal of Oncology, June, 2010: 30-35
  •  Kandel SH, Radwan ER, Eissa E, El-Bassuou, Abd El-Fattah R, Kamel AM.Brain and Acute Leukemia Cytoplasmic (BAALC) Gene Expression in Acute Myeloid Leukemia: A Study of an Egyptian Cohort. JESHR,2010, 6: 31-37
  • Kamel AM, Teama S, Fawzy A, El-Deftar M. Plasma DNA Integrity Index In Breast Cancer Patients. Egyptian Journal of Laboratory Medicine 2010, October, 22; 3: 197-204
  • Kamel AM, Kandeel EZ, El-Sharkawy NM, Moussa HS, Radwan ER, El-Haddad A. Flow Cyometric Detection of Minimal Residual Disease (MRD) in Acute Lymphoblastic Leukemia: Correlation to Other Prognostic Parameters. Journal of the Egyptian Society of Haematology & Research, 2013, 9: 1-7, 
  • El-Rashidi F, El-Haddad A, Kandeel EZ, Deeb M, Soliman MA, Doaa Elian D, Kamel AM. Minimal residual disease as a prognostic factor in childhood acute lymphoblastic leukemia and its relation to other factors. Journal of the Egyptian Society of Hematology & Research, 2013, 9: 59-69 
  • Aboul Naga SA, Ebid GT, Fahmi HM, Zamzam MF, Mahmoud S, Hafez HF and Kamel AM. Effects of Thiopurine S-methyltransferase Genetic Polymorphism on   Mercaptopurine Therapy in Pediatric ALL, Journal of American Science, 2011, April, 7: 337-346 
  • Ebid G, Kamel A, Moussa H and Rong B. In Pediatric acute lymphoblastic leukemia the risk effect of NQO1 C609T polymorphism and the protective effect of MTHFR A1298C polymorphism Neutralize each other. European Hematology Association (EHA) 16th Congress, London, UK, June, 2011
  • Kamel AM, El-Sharkawy NM, Meshaal SS, Labib DA, Kamel MM, Abdelfattah RM, Samra MA, Sherif MM and Gohar OA. Expression of phosphorylated STAT5 in chronic myeloid leukemia: relation to disease stages, European Hematology Association (EHA) 16th Congress, London, UK, June, 2011
  • Kamel AM, Teama S, Fawzy A, El-Deftar M. Plasma DNA Integrity Index In Breast Cancer Patients. Distinguished Abstracts Awards, American Association of Clinical Chemistry (AACC), July, 2011 AACC 11 A 09
  • .Sherborne AL,  Hemminki K, Kumar R, Bartram CR, Stanulla M, Schrappe M,  Petridou E, Semsei AF,  Szalai C, Sinnett D, Krajinovic M, Healy J, Lanciotti M, Dufour C, Indaco S, El-Ghouroury EA, Sawangpanich R, Hongeng S, Pakakasama S, Gonzalez-Neira A,  Ugarte EL, Leal VP, Espinoza JPM, Azza M. Kamel AM,  Ebid GTA Radwan ER, Yalin S, Yalin E, Berkoz M, Simpson J, Roman E, Lightfoot T, Hosking FJ, Vijayakrishnan J, Greaves M and Houlston RS. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia haematologica the haematology journal 2011, 96: 1049-1054  
  • Kamel AM, Mossallam G, Meshaal SS, Labib DA, Abdelfattah RM, Samra MA, Sherif MM and Omaima A Gohar OA. Bcl-xL expression as a potential prognostic parameter in chronic myeloid leukemia, CML – Biology and Therapy, Estoril, Portugal, September, 2011
  • Kamel A, El-Sharkawy N, Kandeel E, Moussa, H, El-Haddad A. Prognostic significance of minimal residual disease in pediatric precursor-B acute lymphoblastic leukemia. 17th congress of the European Hematology Association (EHA), Amesterdam, Netherland, June 14- 17, 2012.  Haematologica 2012; 97(s1): 483 Abstract code:1162
  • Kamel, A, El-Sharkawy, Abd El-Fattah EK, Abd El-Fattah R, Wallace P, Mahmoud HK.   Interleukin 12 (IL12) and Interferon Gamma (IFNʏ) of Donor Origin Not of Patient Origin May Predict Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) 54th Annual meeting of the American Society of Hematology (ASH), Georgia, Atlanta, USA, December 8-11.2012.Publicaion Number 1956. Nov 2012; 120: 195
  • Radwan WM, Moussa HS, Essa ES, Kandil SH, Kamel AM. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients. Asia Pac J Clin Oncol. 2012 Jul 4. doi: 10.1111/j.1743-7563.2012.01556.x. [Epub ahead of print] PMID: 22897908 [PubMed - as supplied by publisher] 2013; 9: 66–70
  • Samra MA, Kamel HM, Abdelhamid TM, Elsharkawy NM, Elnahass YH, Elgammal MM, Abdelfattah RM, Eid S, Ghaleb FM, Kamel AM. The Prognostic Significance of Minimal Residual Disease in Adult Egyptian Patients with Precursor Acute Lymphoblastic Leukemia. JENCI 2013,  25, 135–142
  • Kamel AM, Mossallam G, Meshaal SS, Labib DA, Abdelfattah RM, Samra MA, Sherif MM and Omaima A Gohar OA. Bcl-xL expression as a potential prognostic parameter in chronic myeloid leukemia, CML – Biology and Therapy, 18th congress of the European Hematology Association (EHA), Stockholm, Sweden, June 13- 16, 2013.  Haematologica 2013; 97(s1): 483 Abstract code: B1348
  • Kamel A, Elshakankiry N, Mossallam G, Elfishawi S, Elnahass Y, Kamel H, Elhaddad A. Probability of Finding an HLA-matched Donor: The Egyptian Experience. The 27th European Immunogenetics and Histocompatibility Conference11-13 May, 2013, Amesterdam, Netherland, P 219, Tissue Antigens, 2013, 81: 368
  • Ebid G, Kassem SH, Kamel AM. GSTM1 genotype as a risk modifier of MDR1 C3435T - induced risk susceptibility to pediatric acute lymphoblastic leukemia. 18th congress of the European Hematology Association (EHA), Stockholm, Sweden, June 13- 16, 2013.  Haematologica 2013; 97(s1): 483  
  • kamel AM, El-Sharkawy NM, Abd El-Fattah EK, Abd El-Fattah RM, Samra MA, Wallace PK, Mahmoud HK. Interferon Gamma/IL10 Ratio Production in Response to Host Antigens May Predict Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation from a Sibling. J Leuk 2013, 1:2 http://dx.doi.org/10.4172/jlu.1000111
  • Kamel AM, Kandeel EZ, El-Sharkawy NM, Moussa HS, Radwan ER, El-Haddad A. Flow Cyometric Detection of Minimal Residual Disease (MRD) in Acute Lymphoblastic Leukemia: Correlation to Other Prognostic Parameters. JESHR, 2013, 9: 1-7, 
  • El-Sharkawy NM, Radwan WM, Eissa ES, Kandil SH, Kamel AM.  Detection of brother of the regulator of imprinted sites expression (BORIS) in peripheral blood neutrophils by Flowcytometry in benign and malignant breast lesions, XXVIII Congress of the International Society for Advancement of Cytometry, May 19-22,2013, San Diego, California, USA  Abstract No: 222/B101 page 175
  • Kandeel E and Kamel A "Flow Cytomteric Detection of Minimal Residual Disease", Book ISBN 978-3-659-40576-1.  2013 LAP LAMBERT Academic Publishing (LAP), AV Akademikerverlag GmbH& Co. KG. Heinrich-Böcking-Str. 6-8, 66121, Saarbrücken, Germany
  • kamel AM, Ebid GTA,  Gamil A,  El-Fattah R, Mahmoud HK. Impact Of Patient/Donor Cytokine Genotypes on the Development of Acute Graft Versus Host Disease (aGVHD) After Peripheral Blood Stem Cell Transplantation From An Identical Sibling The 55th  ASH Annual Meeting   December 7-10, 2013, New Orleans, LA Abstract No  5426
  • Kamel AM,  Mira MF, Mossallam GI,  Ebid GTA,  Radwan ER,  Aly Eldin NH, Mamdouh M, Amin M,  Badawy N,  Bazaraa H,  Ibrahim A, N Salah N, Hansen J Lack of association of CTLA-4 +49 A/G polymorphism with predisposition to type 1 diabetes in a cohort of Egyptian families. EJMHG 2014; 15:25-30.
  • kamel AM,  Ebid GTA, Gamil A, Abd El-Fattah R, Mahmoud HK. Transforming growth factor beta gene polymorphism as a risk factor for the developmemt of GVHD after stem cell transplantation from an identical sibling 19th congress of the European Hematology Association (EHA), Milan, Italy, June 12- 15, 2014.  Haematologica 2014; (s1): 1885  .
  • Kamel A, Elshakankiry N, Mossallam G, Elfishawi S, Elnahass Y, Kamel H, Elhaddad A. A comparative study to determine HLA allele frequency in the Egyptian population The 28th European Immunogenetics and Histocompatibility Conference 25-28 June, 2014, Stockholm, Sweden Tissue Antigens Volume 84, Issue 1, Article first published online: 2 JUN 2014.
  • kamel AM, Ebid GTA, Gamil A, Abd El-Fattah R, Mahmoud HK. Interferon Gamma (IFNγ) Gene Polymorphism as a Risk Factor for the Development of GVHD after Stem Cell Transplantation from an Identical Sibling. XXXV World Congress of the International Society of Hematology, Beijing, China, 4-7 Septmber, 2014.
  • Kamel AM, Ebid GTA, Moussa HS. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia. Tumor Biology 2015 Online first (DOI) 10.1007/s13277-015-3320-7. ISSN: 1010-4283 (Print), 1423-0380 (Electronic) Tumor Biology 2015; 36: 6341-6348 
  • Kamel AM, El-Sharkawy NM, Kandeel EZ, Hanafi MM, A Samra MA. Impact of leukemia stem cell frequency at diagnosis on survival in adult acute myeloid leukemia patients. 20th congress of the European Hematology Association (EHA), Vienna, Austria, June 21- 24, 2015.  Haematologica 2015;  (s1). 
  • Kamel A M, Teama S, Fawzi A and El-Deftar M. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer. Tumour Biol. 2016 Jun;37(6):7565-72. doi: 10.1007/s13277-015-4624-3. Epub 2015 Dec 18.
  • Kamel AM, El-Sharkawy NM, Osman RA, Abd El-Fattah EK, El-Noshokaty E, Thoraya Abd El-Hamid T, Kandeel EZ. Adhesion molecules expression in CLL: Potential impact on clinical and hematological parameters. JENCI, 2016, 28: 31-37
  • Elfishawi S, Mossallam G, Elhaddad A, Abdelfattah R, Kamel A. Impact of killer cell immunoglobulin like receptors (KIR) on hematopoieticstem cell transplantation. 10 th East-West Immunogenetics Conference, Vroctaw, Poland, April 21-23, 2016
  • Kamel AM, El-Sharkawy NM, Osman RA, Abd El-Fattah EK, El-Noshokaty E, Thoraya Abd El-Hamid T, Kandeel EZ. Impact of Adhesion molecules expression on nodal and extra-nodal involvement in chronic lymphocytic leukemia. 36th World Congress of the ISH, Glasgow, Scotland, April,18-21, 2016 
  • El-Sharkawy NM, Radwan WM, Eissa ES, Kandeel EZ, Abd El-Fattah EK, Kandil SH, Kamel AM.  Increased Expression of Brother of the Regulator of Imprinted Sites in Peripheral Blood Neutrophils Is Associated with Both Benign and Malignant Breast Lesions. Cytometry Part B (Clinical Cytometry), 2017; 92B:355–360 DOI: 10.1002/cyto.b.21378, Online May 2016 Online ISSN: 1552-4957. Print ISSN: 1552-4949 IF: 2.474
  • El-Fishawi SM, Mossallam G, Abdelfattah R, Elhaddad A, Kamel AM. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling. Human Immunology  2017 78 (11-12):684-691. doi: 10.1016/j.humimm.2017.10.004. ISSN: 0198-8859
  • Kandeel EZ, El Sayed G, Elsharkawy N, Eldin DN, Nassar HR, Ibrahiem D, Amin R, Hanafi M, Khalil M, Kamel A. Impact of FLT3 Receptor (CD135) Detection by Flow Cytometry on Clinical Outcome of Adult Acute Myeloid Leukemia Patients. Clin Lymphoma Myeloma Leuk. 2018 May 26. pii: S2152-2650(18)30155-1. doi: 10.1016/j.clml.2018.05.014. [Epub ahead of print]
  • Kamel AM, El-Fishawi S, Rasekh EO, Radwan ER, Zeidan A, El-Said A, Zaky AH, Abdelfattah M, Refaat A & Abdelfattah R. Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation, Leukemia & Lymphoma  2018 , DOI: 10.1080/10428194.2018.1459608 Received 13 Dec 2017, Accepted 20 Mar 2018, Published online: 04 Jul 2018.
  • Kamel AM, Gameel A, Ebid GTA, Radwan ER, Mohammed Saleh MF, Abdelfattah R.The impact of cytokine gene polymorphisms on the outcome of HLA matched sibling hematopoietic stem cell transplantation. Cytokine. 2018; 110:404-411. doi: 10.1016/j.cyto.2018.05
  • Variability of contribution of 1,25 (OH)2D3 (vitamin D) level to hematopoietic stem cell transplantation outcome XXXVII World Congress International Society of Hematology Vancouver BC, Canada | September 13-16, 2018
  • Kamel AM, Mira MF, Ebid GTA, kassem SH, Radwan ER, Hassan MM, Amin M, Badawi N, Bazaraa H, Ibrahim A, Salah N. Association of Insulin gene VNTR INS -23/Hph1 A>T (rs689) polymorphism with type 1 diabetes mellitus in Egyptian children. EJMHG 2019; 20:1-6 
  • kamel AM, Elsharkawy NM, Abdelfattah EK, Radwan ER, Abdelfattah R, Samra MA, Wallace P, Hossam K Mahmoud HK. IL12 and IFNγ secretion by donor mononuclear cells in response to host antigens may predict acute GVHD after HSCT. Immunobiology 2019; 224(5):659-665. doi: 10.1016/j.imbio.2019.07.001. PMID: 31375357. IF= 2.798.
  • Kandeel EZ, El Sharkawy N, Hanafi M, Mohamed Samra M, Kamel AM. Tracing leukemia stem cells and its influence on clinical course of adult acute myeloid leukemia. Clinical Lymphoma, Myeloma and Leukemia. 2020;  20, (6):  383-393 Available online 12 February 2020. doi:https://doi.org/10.1016/j.clml.2019.11.018. Science Direct. ISSN 2152-2650. 2018 IF 2.274. 
  • Rasekh EO,  Osman R  ,  Ibraheem D,  Madney Y ,  Radwan E , Gameel A,  Abdelhafiz A ,  Kamel A ,  Elfishawi S  Acute lymphoblastic leukemia–like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients. Ann Hematol 2021 Mar;100(3):699-707. 2020 Nov 23.  doi: 10.1007/s00277-020-04354-2. Online ahead of print.
  • Kamel AM, Elsharkawy NM, Kandeel EZ, Hanafi M, Samra M, Osman RA. Leukemia stem cell frequency at diagnosis correlates with measurable/minimal residual disease and impacts survival in adult acute smyeloid leukemia. Frontiers in Oncology, section Hematologic Malignancies 2022, In press.

Awards

  • 1989: State Award in Medicine.
  • 1994: Medal of Excellence from the Egyptian Government.
  • 1996: State Award in Medicine.
  • 1998: Decorated by the Egyptian Medical Syndicate.
  • 2007: Decorated by Cairo Medical Syndicate.
  • 2007: Cairo University Award of Appreciation.
  • 2021: Cairo University Award of Distinction.

Are you interested in submitting your research paper?

Thank you for choosing us. We recommend you to go through our guidelines before submitting the paper.

Submit Manuscript
Logo

Clinical Oncology Journal is the state-of-the-art platform to showcase medical journals across scientific community and a one-stop solution for publishing the manuscripts of varied medical specialities.

Main Links

Useful Links

Our Contacts

CLINICAL ONCOLOGY JOURNAL,
C/O Infact Publications LLC,
16192 Coastal Highway,
Lewes, Delaware 19958
USA

info@clinicaloncologyjournal.com
https://clinicaloncologyjournal.com